Equities

Joincare Pharmaceutical Group Industry Co Ltd

Joincare Pharmaceutical Group Industry Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)9.53
  • Today's Change-0.14 / -1.45%
  • Shares traded9.91m
  • 1 Year change-20.91%
  • Beta1.0996
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments16,17514,97011,895
Total Receivables, Net4,7505,1644,972
Total Inventory2,6562,5622,079
Prepaid expenses288382400
Other current assets, total6.8810019
Total current assets23,87523,17819,365
Property, plant & equipment, net6,5076,4596,120
Goodwill, net636614614
Intangibles, net1,1671,2301,244
Long term investments3,2233,4332,834
Note receivable - long term3.343.3457
Other long term assets----52
Total assets36,35835,73531,104
LIABILITIES
Accounts payable894944872
Accrued expenses5637972,303
Notes payable/short-term debt3,5453,7624,101
Current portion long-term debt/capital leases7196392
Other current liabilities, total4,1394,1891,986
Total current liabilities9,8619,7559,352
Total long term debt3,1383,254852
Total debt7,4027,0795,044
Deferred income tax260237209
Minority interest8,8848,8988,359
Other liabilities, total460469512
Total liabilities22,60222,61319,284
SHAREHOLDERS EQUITY
Common stock1,8661,9291,908
Additional paid-in capital1,6022,3442,265
Retained earnings (accumulated deficit)10,3019,1927,864
Treasury stock - common0(347)(223)
Unrealized gain (loss)(13)17--
Other equity, total0.98(13)5.39
Total equity13,75613,12211,820
Total liabilities & shareholders' equity36,35835,73531,104
Total common shares outstanding1,8661,8671,890
Treasury shares - common primary issue06217
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.